503 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
Alopecia areata is autoimmune hair loss, not pattern baldness. Three FDA-approved JAK inhibitors (Olumiant, Litfulo, Leqselvi) finally treat severe disease — with real…
miraDry is the only FDA-cleared device that permanently destroys underarm sweat glands with microwave energy. It is not for hands or feet, and the Botox comparison is…
Vitiligo is an autoimmune loss of pigment. The 2022 FDA approval of Opzelura (ruxolitinib) made it the first repigmentation drug — used alongside NB-UVB, excimer laser,…
Port-wine stains are congenital vascular malformations; pulsed dye laser is the gold standard. The evidence on timing, session counts, resistant lesions, Sturge-Weber…
Rosacea is treated by matching therapy to the feature that bothers you — redness, bumps, visible vessels, thickened skin, or eye symptoms. The evidence ladder for each,…
Sun spots (solar lentigines) are UV-driven pigment that fades well — once melanoma is ruled out. The evidence ladder: sunscreen, topicals, cryotherapy, peels, IPL, and…
AviClear is a 1726 nm laser FDA-cleared to treat mild to severe inflammatory acne in all skin types. What the clearance means, what the pivotal trial showed, who it…
An analysis of 10 FDA injectable labels: every botulinum toxin carries the same boxed warning, while Kybella does not. A plain map of what the prescribing information…
Stretch marks affect most pregnant people and many teens. An evidence ladder — topicals, microneedling, RF, fractional laser — for early red vs mature white marks, with…
Only two drugs are FDA-approved for pattern hair loss, and both are decades old. An evidence-first guide to minoxidil, finasteride, dutasteride, and the 2026 pipeline…